These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Investigations on the level of circulating eosinophils throughout a 24 hour period in parasitic disease. Burke GJ Trans R Soc Trop Med Hyg; 1975; 69(4):402-5. PubMed ID: 175528 [TBL] [Abstract][Full Text] [Related]
46. Evidence of clonality in cases of hypereosinophilia of undetermined significance. Pohlkamp C; Vetro C; Dicker F; Meggendorfer M; Kern W; Haferlach C; Haferlach T Leuk Lymphoma; 2019 Aug; 60(8):2071-2074. PubMed ID: 30656986 [No Abstract] [Full Text] [Related]
48. [Hypereosinophilia of the blood. II. Classification. Benign essential hypereosinophilia. Eosinophilia caused by systemic eosinophilic hemopathies]. Lovisetto P; Manachino D; Biarese V; Marchi L; Andrione P Minerva Med; 1985 May; 76(22-23):1049-53. PubMed ID: 4011004 [TBL] [Abstract][Full Text] [Related]
49. [Persistent Eosinophilia--differential diagnosis and work-up]. Peduzzi M; Schwitter M; Cathomas R; von Moos R; Wieland T; Mey U Praxis (Bern 1994); 2012 Mar; 101(7):483-7. PubMed ID: 22454311 [TBL] [Abstract][Full Text] [Related]
50. Eosinophilia in primary biliary cirrhosis. Yamazaki K; Nakadate I; Suzuki K; Sato S; Masuda T Am J Gastroenterol; 1996 Mar; 91(3):516-22. PubMed ID: 8633501 [TBL] [Abstract][Full Text] [Related]
51. Lack of basophilia in human parasitic infections. Mitre E; Nutman TB Am J Trop Med Hyg; 2003 Jul; 69(1):87-91. PubMed ID: 12932104 [TBL] [Abstract][Full Text] [Related]
52. [Diagnosis of hypereosinophilia of parasitic etiology (continued)]. Ben Rachid MS; Hafsia A; Mtimet B; Lakhal F; Ben Saïd M; Boussen M Tunis Med; 1985 Jan; 63():15-22. PubMed ID: 3992676 [No Abstract] [Full Text] [Related]
53. Generalized diffuse melanosis evolved from erythroderma with hypereosinophilia and hyper-IgE. Kato T; Kunikata N; Kuroki S; Abe M Skinmed; 2002; 1(2):158-9. PubMed ID: 14673346 [No Abstract] [Full Text] [Related]
54. Is eosinophilia helpful in diagnosing drug eruptions? Berman B; Villa AM Skinmed; 2002; 1(2):147-8. PubMed ID: 14673343 [No Abstract] [Full Text] [Related]
55. Evaluation of the common conditions associated with eosinophilia. Teo CG; Singh M; Ting WC; Ho LC; Ong YW; Seet LC J Clin Pathol; 1985 Mar; 38(3):305-8. PubMed ID: 3973055 [TBL] [Abstract][Full Text] [Related]
56. Effect of adrenaline and isoprenaline on circulating eosinophils in tropical pulmonary eosinophilia. Saran R Indian J Med Res; 1978 Mar; 67():439-42. PubMed ID: 689719 [No Abstract] [Full Text] [Related]
57. [Hypereosinophilia: focus on clinical aspects]. Cogan E Rev Med Brux; 1994; 15(2):55-60. PubMed ID: 8029573 [TBL] [Abstract][Full Text] [Related]
58. [Eosinophilic granulocyte-associated diseases. Current aspects of pathogenesis and therapy]. Kroegel C; Virchow JC; Kortsik C; Costabel U; Werner P; Matthys H Med Monatsschr Pharm; 1993 Jan; 16(1):2-13. PubMed ID: 8433673 [No Abstract] [Full Text] [Related]
59. Evaluation and Differential Diagnosis of Hypereosinophilia in Rheumatology Practice. Üsküdar Cansu D; Üsküdar Teke H; Yildirim R; Dinler M; Korkmaz C Int Arch Allergy Immunol; 2022; 183(1):51-58. PubMed ID: 34515135 [TBL] [Abstract][Full Text] [Related]
60. [Eosinophilia: from neoplastic disease to anguillulosis]. Guinat M; Rusca M; Stalder M; Praz G Rev Med Suisse; 2014 Oct; 10(445):1853-4, 1856-8. PubMed ID: 25417354 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]